ENH make the modeling section better
This commit is contained in:
parent
9e9d897fae
commit
be2bf9fa95
|
@ -2425,6 +2425,32 @@ CONCLUSIONS: We developed a simplified, semi-closed system for the initial selec
|
||||||
publisher = {Wiley},
|
publisher = {Wiley},
|
||||||
}
|
}
|
||||||
|
|
||||||
|
@Article{Qiu2011,
|
||||||
|
author = {Peng Qiu and Erin F Simonds and Sean C Bendall and Kenneth D Gibbs and Robert V Bruggner and Michael D Linderman and Karen Sachs and Garry P Nolan and Sylvia K Plevritis},
|
||||||
|
journal = {Nature Biotechnology},
|
||||||
|
title = {Extracting a cellular hierarchy from high-dimensional cytometry data with {SPADE}},
|
||||||
|
year = {2011},
|
||||||
|
month = {oct},
|
||||||
|
number = {10},
|
||||||
|
pages = {886--891},
|
||||||
|
volume = {29},
|
||||||
|
doi = {10.1038/nbt.1991},
|
||||||
|
publisher = {Springer Science and Business Media {LLC}},
|
||||||
|
}
|
||||||
|
|
||||||
|
@Article{Qiu2017,
|
||||||
|
author = {Peng Qiu},
|
||||||
|
journal = {Cytometry Part A},
|
||||||
|
title = {Toward deterministic and semiautomated {SPADE} analysis},
|
||||||
|
year = {2017},
|
||||||
|
month = {feb},
|
||||||
|
number = {3},
|
||||||
|
pages = {281--289},
|
||||||
|
volume = {91},
|
||||||
|
doi = {10.1002/cyto.a.23068},
|
||||||
|
publisher = {Wiley},
|
||||||
|
}
|
||||||
|
|
||||||
@Comment{jabref-meta: databaseType:bibtex;}
|
@Comment{jabref-meta: databaseType:bibtex;}
|
||||||
|
|
||||||
@Comment{jabref-meta: grouping:
|
@Comment{jabref-meta: grouping:
|
||||||
|
|
|
@ -123,6 +123,7 @@
|
||||||
\newacronym{colb}{COL-B}{collagenase B}
|
\newacronym{colb}{COL-B}{collagenase B}
|
||||||
\newacronym{cold}{COL-D}{collagenase D}
|
\newacronym{cold}{COL-D}{collagenase D}
|
||||||
\newacronym{tsne}{tSNE}{t-stochastic neighbor embedding}
|
\newacronym{tsne}{tSNE}{t-stochastic neighbor embedding}
|
||||||
|
\newacronym{umap}{UMAP}{uniform manifold approximation and projection}
|
||||||
\newacronym{anv}{AXV}{Annexin-V}
|
\newacronym{anv}{AXV}{Annexin-V}
|
||||||
\newacronym{pi}{PI}{propidium iodide}
|
\newacronym{pi}{PI}{propidium iodide}
|
||||||
\newacronym{rt}{RT}{room temperature}
|
\newacronym{rt}{RT}{room temperature}
|
||||||
|
@ -1103,48 +1104,68 @@ directions for future work. To this end, the types of \glspl{doe} we generally
|
||||||
used in this work were fractional factorial designs with three levels, which
|
used in this work were fractional factorial designs with three levels, which
|
||||||
enable the estimation of both main effects and second order quadratic effects.
|
enable the estimation of both main effects and second order quadratic effects.
|
||||||
|
|
||||||
\subsection*{identification and standardization of CPPs and CQAs}\label{sec:background_cqa}
|
\subsection*{identification and standardization of CPPs and
|
||||||
|
CQAs}\label{sec:background_cqa}
|
||||||
|
|
||||||
Ultimately the identification of relevant \glspl{cpp} and \glspl{cqa} is an
|
% BACKGROUND at least attempt to show that there is alot of work in the space
|
||||||
interative process
|
% identifying signaling networks
|
||||||
|
|
||||||
A number of multiomics strategies exist which can generate rich datasets for T
|
In the context of T cell manufacturing, ideally we would have a set of
|
||||||
cells. We will consider several multiomics strategies within this proposal:
|
non-destructive biomarkers that could both identify functional T cells and
|
||||||
|
predict when a process is on track to deliver such functional T cells. T cells
|
||||||
|
secrete numerous cytokines and metabolites in the media, which may reflect the
|
||||||
|
internal state accurately and thus serve as a potential set of \glspl{cqa}.
|
||||||
|
|
||||||
|
The complexity of these pathways dictates that we take a big-data approach to
|
||||||
|
this problem. To this end, there are several pertinent multi-omic (or simply
|
||||||
|
`omic') techniques that can be used to collect such datasets, which can then be
|
||||||
|
mined, modeled, and correlated to relevent responses (such as an endpoint
|
||||||
|
quantification of memory T cells) to identify pertinent \glspl{cqa}.
|
||||||
|
|
||||||
|
An overview of the techniques used in this work are:
|
||||||
|
|
||||||
\begin{description}
|
\begin{description}
|
||||||
\item[Luminex:] A multiplexed bead-based \gls{elisa} that can measure
|
\item[Luminex --] This is a multiplexed bead-based assay similar to \gls{elisa} that can measure
|
||||||
many bulk (not single cell) cytokine concentrations simultaneously
|
many bulk (not single cell) cytokine concentrations simultaneously
|
||||||
in a media sample. Since this only requires media (as opposed to
|
in a media sample. This is a destructive assay but does not require cells to
|
||||||
destructively measuring cells) we will use this as a longitudinal
|
obtain a measurement.
|
||||||
measurement.
|
\item[\gls{nmr} --] It is well known that T cells of different
|
||||||
\item[Metabolomics:] It is well known that T cells of different
|
|
||||||
lineages have different metabolic profiles; for instance memory T
|
lineages have different metabolic profiles; for instance memory T
|
||||||
cells have larger aerobic capacity and fatty acid
|
cells have larger aerobic capacity and fatty acid
|
||||||
oxidation\cite{Buck2016, van_der_Windt_2012}. We will interrogate
|
oxidation\cite{Buck2016, van_der_Windt_2012}. \gls{nmr} is a technique that
|
||||||
key metabolic species using \gls{nmr} in collaboration with the
|
can non-destructively quantify small molecules in a media sample, and thus is
|
||||||
Edison Lab at the University of Georgia. This will be both a
|
an attractive method that could be used for inline, real-time monitoring.
|
||||||
longitudinal assay using media samples (since some metabolites may
|
\item[Flow and Mass Cytometry --] Flow cytometry using fluorophores has been
|
||||||
be expelled from cells that are indicative of their phenotype) and
|
used extensively for immune cell analysis, but has a practical limit of
|
||||||
at endpoint where we will lyse the cells and interogate their entire
|
|
||||||
metabolome.
|
|
||||||
\item[Flow and Mass Cytometry:] Flow cytometry using fluorophores has been used
|
|
||||||
extensively for immune cell analysis, but has a practical limit of
|
|
||||||
approximately 18 colors\cite{Spitzer2016}. Mass cytometry is analogous to
|
approximately 18 colors\cite{Spitzer2016}. Mass cytometry is analogous to
|
||||||
traditional flow cytometry except that it uses heavy-metal \gls{mab}
|
traditional flow cytometry except that it uses heavy-metal \gls{mab}
|
||||||
conjugates, which has a practical limit of over 50 markers. This will be
|
conjugates, which has a practical limit of over 50 markers. While mass
|
||||||
useful in determining precise subpopulations and phenotypes that may be
|
cytometry is less practical than simple flow cytometers such as the BD Accuri,
|
||||||
influencing responses, especially when one considers that many cell types can
|
we may find that only a few markers are required to accurately predict
|
||||||
be defined by more than one marker combination. We will perform this at
|
performance, and thus this could easily translate to industry using relatively
|
||||||
endpoint. While mass cytometry is less practical than simple flow cytometers
|
cost-effective equipment. Both of these destructively analyze the cells
|
||||||
such as the BD Accuri, we may find that only a few markers are required to
|
themselves, but they have the advantage in that they are measuring a direct
|
||||||
accurately predict performance, and thus this could easily translate to
|
property of the cells and not a secreted product.
|
||||||
industry using relatively cost-effective equipment.
|
|
||||||
\end{description}
|
\end{description}
|
||||||
|
|
||||||
% TODO add a computational section
|
% BACKGROUND what about ssRNAseq?
|
||||||
|
|
||||||
% TODO add a section explaining causal inference since this is a big part of
|
Upon collecting these omic datasets, determining the \glspl{cqa} becomes a
|
||||||
% the end of aim 1
|
computational problem. Predictions of the final product using data collected
|
||||||
|
earlier in time can be made using any number of supervised learning techniques
|
||||||
|
(linear and non-linear regression in all its forms) which in turn can be used to
|
||||||
|
develop process control models. Unsupervised learning and dimensionality
|
||||||
|
reduction techniques such as \gls{tsne}, \gls{umap}, and
|
||||||
|
\gls{spade}\cite{Qiu2011, Qiu2017} can be performed to delineate clusters of
|
||||||
|
interesting cell types and the markers that define them.
|
||||||
|
|
||||||
|
Ultimately, identifying \glspl{cqa} will likely be an iterative process, wherein
|
||||||
|
putative \glspl{cqa} will be identified, the corresponding \glspl{cpp} will be
|
||||||
|
set and optimized to maximize products with these \glspl{cpp} and then
|
||||||
|
additional data will be collected in the clinic as the product is tested on
|
||||||
|
various patients with different indications. Additional \glspl{cqa} may be
|
||||||
|
identified which better predict specific clinical outcomes, which can be fed
|
||||||
|
back into the process model and optimized again.
|
||||||
|
|
||||||
\section{Innovation}
|
\section{Innovation}
|
||||||
|
|
||||||
|
|
Loading…
Reference in New Issue